Alistair Ring

5.6k total citations
108 papers, 2.5k citations indexed

About

Alistair Ring is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alistair Ring has authored 108 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 55 papers in Cancer Research and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alistair Ring's work include Breast Cancer Treatment Studies (37 papers), HER2/EGFR in Cancer Research (23 papers) and Advanced Breast Cancer Therapies (20 papers). Alistair Ring is often cited by papers focused on Breast Cancer Treatment Studies (37 papers), HER2/EGFR in Cancer Research (23 papers) and Advanced Breast Cancer Therapies (20 papers). Alistair Ring collaborates with scholars based in United Kingdom, United States and France. Alistair Ring's co-authors include Mitch Dowsett, Ian E. Smith, Sunil R. Lakhani, M.G. Ormerod, Lila Zabaglo, S. Ashley, Laura Fulford, Peter Ellis, Nicolò Matteo Luca Battisti and Marina Parton and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Alistair Ring

102 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alistair Ring United Kingdom	25	1.4k	1.1k	557	556	397	108	2.5k
Yuan Yuan United States	30	1.7k 1.2×	1.2k 1.1×	735 1.3×	1.5k 2.8×	321 0.8×	168	3.6k
Indraneel Mittra India	26	1.3k 0.9×	872 0.8×	338 0.6×	457 0.8×	296 0.7×	84	2.6k
Debasish Tripathy United States	21	1.7k 1.2×	1.2k 1.0×	484 0.9×	778 1.4×	390 1.0×	54	2.8k
Erica L. Mayer United States	31	2.6k 1.8×	1.2k 1.1×	997 1.8×	1.4k 2.5×	495 1.2×	144	4.7k
Kathrin Strasser‐Weippl Austria	20	1.2k 0.8×	864 0.8×	408 0.7×	657 1.2×	482 1.2×	61	2.5k
Laura Orlando Italy	27	1.9k 1.3×	1.3k 1.2×	543 1.0×	946 1.7×	321 0.8×	92	2.9k
Neelima Denduluri United States	23	1.7k 1.2×	821 0.7×	700 1.3×	379 0.7×	203 0.5×	67	2.8k
John F. Sandbach United States	15	1.5k 1.0×	864 0.8×	360 0.6×	661 1.2×	413 1.0×	32	2.4k
Tiffany A. Traina United States	30	2.4k 1.7×	1.6k 1.4×	1.4k 2.5×	1.1k 1.9×	698 1.8×	146	4.0k
Aurelius Omlin Switzerland	32	1.3k 0.9×	985 0.9×	1.9k 3.4×	816 1.5×	169 0.4×	115	3.6k

Countries citing papers authored by Alistair Ring

Since Specialization

Citations

This map shows the geographic impact of Alistair Ring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair Ring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair Ring more than expected).

Fields of papers citing papers by Alistair Ring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alistair Ring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair Ring. The network helps show where Alistair Ring may publish in the future.

Co-authorship network of co-authors of Alistair Ring

This figure shows the co-authorship network connecting the top 25 collaborators of Alistair Ring. A scholar is included among the top collaborators of Alistair Ring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair Ring. Alistair Ring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cutts, Rosalind, Matthew Beaney, M Robert, et al.. (2024). Association of post-operative ctDNA detection with outcomes of patients with early breast cancers. ESMO Open. 9(9). 103687–103687. 12 indexed citations

Cutts, Ros, Sarah Hrebien, Aditi Gulati, et al.. (2024). Discriminating subtypes in advanced breast cancer with ctDNA methylation profiling.. Journal of Clinical Oncology. 42(16_suppl). 1013–1013.

Welch, Christine A., Nicolò Matteo Luca Battisti, Michael Sweeting, et al.. (2023). Geographical Variation in Underlying Social Deprivation, Cardiovascular and Other Comorbidities in Patients with Potentially Curable Cancers in England: Results from a National Registry Dataset Analysis. Clinical Oncology. 35(12). e708–e719. 3 indexed citations

Harper‐Wynne, Catherine, et al.. (2023). A disease registry study to prospectively observe treatment patterns and outcomes in patients with HER2+ unresectable locally advanced or metastatic breast cancer (aBC): Interim results of the ESTHER study (NCT02393924).. Journal of Clinical Oncology. 41(16_suppl). e13039–e13039. 1 indexed citations

Kingston, Belinda, Alex Pearson, María Teresa Herrera-Abreu, et al.. (2023). ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1 -Mutant Breast Cancer. Cancer Discovery. 14(2). 274–289. 21 indexed citations

Ring, Alistair, Meghan Karuturi, Emily Nash Smyth, et al.. (2023). Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice. Advances in Therapy. 40(5). 2515–2523. 3 indexed citations

Cottu, Paul, Alistair Ring, Hikmat Abdel‐Razeq, et al.. (2022). Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: Subgroup analysis of the phase IIIb CompLEEment-1 trial. The Breast. 62. 75–83. 13 indexed citations

Okines, Alicia, Kabir Mohammed, Peter Osin, et al.. (2022). Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience. Breast Cancer Research and Treatment. 192(3). 563–571. 3 indexed citations

Battisti, Nicolò Matteo Luca, Belinda Kingston, Judy King, et al.. (2019). Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience. Breast Cancer Research and Treatment. 174(3). 731–740. 15 indexed citations

10.

Lifford, Kate, Adrian Edwards, Maria Burton, et al.. (2019). Efficient development and usability testing of decision support interventions for older women with breast cancer. Patient Preference and Adherence. Volume 13. 131–143. 5 indexed citations

11.

Kingston, Belinda, Stefania Redana, Eleftheria Kalaitzaki, et al.. (2017). Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience. The Breast. 36. 54–59. 28 indexed citations

12.

Sinha, R. K., et al.. (2017). Comprehensive geriatric assessment in 326 older women with early breast cancer. British Journal of Cancer. 117(7). 925–931. 26 indexed citations

13.

Appleyard, Sharon A., Duncan C. Gilbert, Christopher I. Jones, et al.. (2017). Comprehensive Geriatric Assessment in Men Aged 70 Years or Older with Localised Prostate Cancer Undergoing Radical Radiotherapy. Clinical Oncology. 29(9). 609–616. 21 indexed citations

14.

Battisti, Nicolò Matteo Luca, et al.. (2017). Outcomes of systemic therapy for advanced triple-negative breast cancer: A single centre experience. Annals of Oncology. 28. v88–v88. 1 indexed citations

15.

Ring, Alistair, Duncan Wheatley, Helen Hatcher, et al.. (2014). Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast Cancer. Clinical Cancer Research. 21(12). 2737–2744. 16 indexed citations

16.

Sourij, Harald, et al.. (2013). Adding value to the experience of attending a diabetes clinic appointment: provision of personalised 10 year cardiovascular disease (CVD) risk estimates. Diabetic Medicine. 30. 194–194. 1 indexed citations

17.

Ring, Alistair, Ivana Šestak, Michael Baum, et al.. (2011). Influence of Comorbidities and Age on Risk of Death Without Recurrence: A Retrospective Analysis of the Arimidex, Tamoxifen Alone or in Combination Trial. Journal of Clinical Oncology. 29(32). 4266–4272. 50 indexed citations

18.

Leonard, Robert, Rachel Ballinger, David Cameron, et al.. (2011). Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?. British Journal of Cancer. 105(9). 1260–1266. 33 indexed citations

19.

Ring, Alistair & Peter Ellis. (2002). Predictors of response to systemic therapy in breast cancer. The Forum. 12(1). 19–32. 1 indexed citations

20.

Ring, Alistair & Peter Ellis. (2002). Predictors of response to systemic therapy in breast cancer.. PubMed. 12(1). 19–32. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact